Androgen deprivation-induced OPHN1 amplification promotes castration-resistant prostate cancer

Androgen deprivation therapy (ADT) is used to treat prostate cancer (PCa). However, ADT may increase the expression of androgen receptor (AR) through the amplification of chromosome X. The gene oligophrenin 1 (OPHN1) is located in the same region as the AR gene, which could be amplified by ADT. Thus...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Junjiang, Zhang, Yunxia, Li, Shoubin, Sun, Fuzhen, Wang, Gang, Wei, Dong, Yang, Tao, Gu, Shouyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600397/
https://www.ncbi.nlm.nih.gov/pubmed/34738630
http://dx.doi.org/10.3892/or.2021.8214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600397/
https://www.ncbi.nlm.nih.gov/pubmed/34738630
http://dx.doi.org/10.3892/or.2021.8214

Ejemplares similares